Previous close | 27.89 |
Open | 27.89 |
Bid | 0.00 |
Ask | 0.00 |
Strike | 135.00 |
Expiry date | 2025-01-17 |
Day's range | 27.89 - 27.89 |
Contract range | N/A |
Volume | |
Open interest | N/A |
Rewards that the next bull market will bring are being built right now by farsighted investors who can find opportunities among today's discounted stocks. While there's no telling exactly when a bull market will develop, planting the seeds of success by buying some shares of cheap yet high-quality companies out there right now is a good move. With that in mind, here are two businesses you're probably acquainted with that are priced for a no-brainer purchase -- and have a good shot at flourishing in the next bull market and beyond.
There's a pretty good chance Warren Buffett knows a few things about investing that we don't. Let's take a look at three of his most likely arguments against buying biotechs. Biotech stocks are risky, and there isn't really any way of de-risking their line of business, both of which are things that Buffett almost certainly hates about them.
While Moderna, Inc. ( NASDAQ:MRNA ) shareholders have had a good week with the stock up 8.5%, they shouldn't let their...